印度国家药物教育研究所Banerjee等 | 细胞之间的相互作用在3D体外微生理学疾病模型中的体细胞布局菌群-肠-脑轴上的影响

上下滑动以阅览

1. Martin CR, Osadchiy V, Kalani A et al (2018) The brain-gut-microbiome axis. CMGH 6(2):133–148. https://doi.org/10.1016/j.jcmgh.2018.04.003

2. Guo YX, Chen XF, Gong P et al (2023) The gut-organ-axis concept: advances the application of gut-on-chip technology. Int J Mol Sci 24(4):4089. https://doi.org/10.3390/ijms24044089

3. Nandwana V, Nandwana NK, Das Y et al (2022) The role of microbiome in brain development and neurodegenerative diseases. Molecules 27(11):3402. https://doi.org/10.3390/molecules27113402

4. Langille MGI, Zaneveld J, Caporaso JG et al (2013) Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31(9):814–821. https://doi.org/10.1038/nbt.2676

5. Eng A, Borenstein E (2018) Taxa-function robustness in microbial communities. Microbiome 6(1):45. https://doi.org/10.1186/s40168-018-0425-4

6. Cryan JF, O’Riordan KJ, Sandhu K et al (2020) The gut microbiome in neurological disorders. Lancet Neurol 19(2):179–194. https://doi.org/10.1016/S1474-4422(19)30356-4

7. Zhang HM, Chen YJ, Wang ZF et al (2022) Implications of gut microbiota in neurodegenerative diseases. Front Immunol 13:785644. https://doi.org/10.3389/fimmu.2022.785644

8. Martinez JE, Kahana DD, Ghuman S et al (2021) Unhealthy lifestyle and gut dysbiosis: a better understanding of the effects of poor diet and nicotine on the intestinal microbiome. Front Endocrinol 12:667066. https://doi.org/10.3389/fendo.2021.667066

9. Pizarroso NA, Fuciños P, Gonçalves C et al (2021) A review on the role of food-derived bioactive molecules and the microbiota–gut–brain axis in satiety regulation. Nutrients 13(2):632. https://doi.org/10.3390/nu13020632

10. Kho ZY, Lal SK (2018) The human gut microbiome: a potential controller of wellness and disease. Front Microbiol 9:1835. https://doi.org/10.3389/fmicb.2018.01835

11. Shang H, Zhao X, Zhang X (2023) Neurodegenerative diseases. In: Liu HS, Zhang XA (Eds.), Pediatric Neuroimaging: Cases and Illustrations. Springer, Singapore, p.211–214. https://doi.org/10.1007/978-981-16-7928-5_8

12. Chapter Google Scholar Fung TC, Olson CA, Hsiao EY (2017) Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20(2):145–155. https://doi.org/10.1038/nn.4476

13. Heijtz RD, Wang SG, Anuar F et al (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108(7):3047–3052. https://doi.org/10.1073/pnas.1010529108

14. Wendeln AC, Degenhardt K, Kaurani L et al (2018) Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556(7701):332–338. https://doi.org/10.1038/s41586-018-0023-4

15. Gebrayel P, Nicco C, Al Khodor S et al (2022) Microbiota medicine: towards clinical revolution. J Transl Med 20(1):111. https://doi.org/10.1186/s12967-022-03296-9

16. Braniste V, Al-Asmakh M, Kowal C et al (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6(263):263ra158. https://doi.org/10.1126/scitranslmed.3009759

17. Adjei AA, Christian M, Ivy P (2009) Novel designs and end points for phase II clinical trials. Clin Cancer Res 15(6):1866–1872. https://doi.org/10.1158/1078-0432.CCR-08-2035

18. Shepherd A, Zhang TD, Zeleznikow-Johnston AM et al (2018) Transgenic mouse models as tools for understanding how increased cognitive and physical stimulation can improve cognition in Alzheimer’s disease. Brain Plast 4(1):127–150. https://doi.org/10.3233/bpl-180076

19. Götz J, Ittner LM, Schonrock N et al (2008) An update on the toxicity of Aβ in Alzheimer’s disease. Neuropsychiatr Dis Treat 4(6):1033–1042. https://doi.org/10.2147/ndt.s3016

20. Hargis KE, Blalock EM (2017) Transcriptional signatures of brain aging and Alzheimer’s disease: what are our rodent models telling us? Behav Brain Res 322(Pt B):311–328. https://doi.org/10.1016/j.bbr.2016.05.007

21. Ravussin Y, Koren O, Spor A et al (2012) Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity 20(4):738–747. https://doi.org/10.1038/oby.2011.111

22. Zhang CY, Franklin CL, Ericsson AC (2021) Consideration of gut microbiome in murine models of diseases. Microorganisms 9(5):1062. https://doi.org/10.3390/microorganisms9051062

23. Ambrosini YM, Borcherding D, Kanthasamy A et al (2019) The gut-brain axis in neurodegenerative diseases and relevance of the canine model: a review. Front Aging Neurosci 11:130. https://doi.org/10.3389/fnagi.2019.00130

24. Zhang L, Fitzloff JF, Engel LC et al (2001) Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide. Xenobiotica 31(2):73–83. https://doi.org/10.1080/00498250110037488

25. Ding JH, Jin Z, Yang XX et al (2020) Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol 26(40):6141–6162. https://doi.org/10.3748/wjg.v26.i40.6141

26. Thergarajan G, Bhassu S (2022) The interaction of gut microbiota-brain axis in relation to human health with the use of animal models. In: Hoda El-Sayed (Ed.), Effect of Microbiota on Health and Disease. IntechOpen. https://doi.org/10.5772/intechopen.105866

27. Chapter Google Scholar Bertotto LB, Catron TR, Tal T (2020) Exploring interactions between xenobiotics, microbiota, and neurotoxicity in zebrafish. Neurotoxicology 76:235–244. https://doi.org/10.1016/j.neuro.2019.11.008

28. Landi M, Everitt J, Berridge B (2021) Bioethical, reproducibility, and translational challenges of animal models. ILAR J 62(1–2):60–65. https://doi.org/10.1093/ilar/ilaa027

29. Biagini F, Daddi C, Calvigioni M et al (2023) Designs and methodologies to recreate in vitro human gut microbiota models. Biodes Manuf 6(3):298–318. https://doi.org/10.1007/s42242-022-00210-6

30. Lechuga S, Braga-Neto MB, Naydenov NG et al (2023) Understanding disruption of the gut barrier during inflammation: should we abandon traditional epithelial cell lines and switch to intestinal organoids? Front Immunol 14:1108289. https://doi.org/10.3389/fimmu.2023.1108289

31. Pearce SC, Coia HG, Karl JP et al (2018) Intestinal in vitro and ex vivo models to study host-microbiome interactions and acute stressors. Front Physiol 9:1584. https://doi.org/10.3389/fphys.2018.01584

32. El Houari A, Ecale F, Mercier A et al (2022) Development of an in vitro model of human gut microbiota for screening the reciprocal interactions with antibiotics, frugs, and xenobiotics. Front Microbiol 13:828359. https://doi.org/10.3389/fmicb.2022.828359

33. Bermudez-Brito M, Muñoz-Quezada S, Gómez-Llorente C et al (2015) Lactobacillus paracasei CNCM I-4034 and its culture supernatant modulate Salmonella-induced inflammation in a novel transwell co-culture of human intestinal-like dendritic and Caco-2 cells. BMC Microbiol 15(1):79. https://doi.org/10.1186/s12866-015-0408-6

34. Rutsch A, Kantsjö JB, Ronchi F (2020) The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol 11:604179. https://doi.org/10.3389/fimmu.2020.604179

35. Cryan JF, O’riordan KJ, Cowan CSM et al (2019) The microbiota-gut-brain axis. Physiol Rev 99(4):1877–2013. https://doi.org/10.1152/physrev.00018.2018

36. Mayer EA, Tillisch K, Gupta A (2015) Gut/brain axis and the microbiota. J Clin Invest 125(3):926–938. https://doi.org/10.1172/JCI76304

37. Wehrwein EA, Orer HS, Barman SM (2016) Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system. Compr Physiol 6(3):1239–1278. https://doi.org/10.1002/cphy.c150037

38. Mayer EA, Tillisch K (2011) The brain-gut axis in abdominal pain syndromes. Annu Rev Med 62(1):381–396. https://doi.org/10.1146/annurev-med-012309-103958

39. Kunze WA, Mao YK, Wang BX et al (2009) Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med 13(8b):2261–2270. https://doi.org/10.1111/j.1582-4934.2009.00686.x

40. McVey Neufeld KA, Mao YK, Bienenstock J et al (2013) The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol Motil 25(2):183-e88. https://doi.org/10.1111/nmo.12049

41. Burokas A, Moloney RD, Dinan TG et al (2015) Microbiota regulation of the mammalian gut-brain axis. Adv Appl Microbiol 91:1–62. https://doi.org/10.1016/bs.aambs.2015.02.001

42. Bravo JA, Forsythe P, Chew MV et al (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108(38):16050–16055. https://doi.org/10.1073/pnas.1102999108

43. Perez-Burgos A, Mao YK, Bienenstock J et al (2014) The gut-brain axis rewired: adding a functional vagal nicotinic “sensory synapse.” FASEB J 28(7):3064–3074. https://doi.org/10.1096/fj.13-245282

44. Chen S, Chen HS, Du QH et al (2020) Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: potential application of natural compounds. Front Physiol 11:433. https://doi.org/10.3389/fphys.2020.00433

45. Bercik P, Park AJ, Sinclair D et al (2011) The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23(12):1132–1139. https://doi.org/10.1111/j.1365-2982.2011.01796.x

46. Ahmed H, Leyrolle Q, Koistinen V et al (2022) Microbiota-derived metabolites as drivers of gut–brain communication. Gut Microbes 14(1):2102878. https://doi.org/10.1080/19490976.2022.2102878

47. Bravo JA, Julio-Pieper M, Forsythe P et al (2012) Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol 12(6):667–672. https://doi.org/10.1016/j.coph.2012.09.010

48. Brun P, Giron MC, Qesari M et al (2013) Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology 145(6):1323–1333. https://doi.org/10.1053/j.gastro.2013.08.047

49. Barajon I, Serrao G, Arnaboldi F et al (2009) Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem 57(11):1013–1023. https://doi.org/10.1369/jhc.2009.953539

50. Mao YK, Kasper DL, Wang BX et al (2013) Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun 4(1):1465. https://doi.org/10.1038/ncomms2478

51. Lyte M (2014) Host-microbiota neuroendocrine interactions influencing brain and behavior. Gut Microbes 5(3):381–389. https://doi.org/10.4161/gmic.28682

52. Lyte M (1993) The role of microbial endocrinology in infectious disease. J Endocrinol 137(3):343–345. https://doi.org/10.1677/joe.0.1370343

53. Strandwitz P (2018) Neurotransmitter modulation by the gut microbiota. Brain Res 1693(Pt B):128–133. https://doi.org/10.1016/j.brainres.2018.03.015

54. Özoǧul F, Kuley E, Özoǧul Y et al (2012) The function of lactic acid bacteria on biogenic amines production by food-borne pathogens in arginine decarboxylase broth. Food Sci Technol Res 18(6):795–804. https://doi.org/10.3136/fstr.18.795

55. Yano JM, Yu K, Donaldson GP et al (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161(2):264–276. https://doi.org/10.1016/j.cell.2015.02.047

56. Waclawiková B, Codutti A, Alim K et al (2022) Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies. Gut Microbes 14(1):1997296. https://doi.org/10.1080/19490976.2021.1997296

57. Hata T, Asano Y, Yoshihara K et al (2017) Regulation of gut luminal serotonin by commensal microbiota in mice. PLoS ONE 12(7):e0180745. https://doi.org/10.1371/journal.pone.0180745

58. Betari N, Sahlholm K, Morató X et al (2020) Inhibition of tryptophan hydroxylases and monoamine oxidase-A by the proton pump inhibitor, omeprazole—in vitro and in vivo investigations. Front Pharmacol 11:593416. https://doi.org/10.3389/fphar.2020.593416

59. Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25(1):131–147. https://doi.org/10.1038/s41380-019-0414-4

60. Kennedy PJ, Cryan JF, Dinan TG et al (2017) Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology 112(Pt B):399–412. https://doi.org/10.1016/j.neuropharm.2016.07.002

61. Cataldo PG, Villena J, Elean M et al (2020) Immunomodulatory properties of a γ-aminobutyric acid-enriched strawberry juice produced by levilactobacillus brevis CRL 2013. Front Microbiol 11:610016. https://doi.org/10.3389/fmicb.2020.610016

62. Matsumoto M, Kibe R, Ooga T et al (2012) Impact of intestinal microbiota on intestinal luminal metabolome. Sci Rep 2(1):233. https://doi.org/10.1038/srep00233

63. Pérez-Berezo T, Pujo J, Martin P et al (2017) Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle. Nat Commun 8(1):1314. https://doi.org/10.1038/s41467-017-01403-9

64. Pokusaeva K, Johnson C, Luk B et al (2017) GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine. Neurogastroenterol Motil 29(1):e12904. https://doi.org/10.1111/nmo.12904

65. Dahlin M, Elfving Å, Ungerstedt U et al (2005) The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res 64(3):115–125. https://doi.org/10.1016/j.eplepsyres.2005.03.008

66. Stefano GB, Kream RM, Esch T (2023) Mobility coupled with motivation promotes survival: the evolution of cognition as an adaptive strategy. Biology 12(1):80. https://doi.org/10.3390/biology12010080

67. Freestone PP, Williams PH, Haigh RD et al (2002) Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 18(5):465–470. https://doi.org/10.1097/00024382-200211000-00014

68. O’Donnell PM, Aviles H, Lyte M et al (2006) Enhancement of in vitro growth of pathogenic bacteria by norepinephrine: importance of inoculum density and role of transferrin. Appl Environ Microbiol 72(7):5097–5099. https://doi.org/10.1128/AEM.00075-06

69. Lyte M, Villageliú DN, Crooker BA et al (2018) Symposium review: microbial endocrinology—why the integration of microbes, epithelial cells, and neurochemical signals in the digestive tract matters to ruminant health1. J Dairy Sci 101(6):5619–5628. https://doi.org/10.3168/jds.2017-13589

70. Curtis MM, Russell R, Moreira CG et al (2014) QseC inhibitors as an antivirulence approach for gram-negative pathogens. mBio 5(6):e02165. https://doi.org/10.1128/mBio.02165-14

71. Giaroni C, De Ponti F, Cosentino M et al (1999) Plasticity in the enteric nervous system. Gastroenterology 117(6):1438–1458. https://doi.org/10.1016/S0016-5085(99)70295-7

72. Asano Y, Hiramoto T, Nishino R et al (2012) Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303(11):G1288–G1295. https://doi.org/10.1152/ajpgi.00341.2012

73. Gubert C, Gasparotto J, Morais LH et al (2022) Convergent pathways of the gut microbiota-brain axis and neurodegenerative disorders. Gastroenterol Rep 10:goac017. https://doi.org/10.1093/gastro/goac017

74. Erny D, De Angelis ALH, Jaitin D et al (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18(7):965–977. https://doi.org/10.1038/nn.4030

75. Colombo AV, Sadler RK, Llovera G et al (2021) Microbiota-derived short chain fatty acids modulate microglia and promote aβ plaque deposition. eLife 10:e59826. https://doi.org/10.7554/ELIFE.59826

76. El Aidy S, Dinan TG, Cryan JF (2015) Gut microbiota: the conductor in the orchestra of immune-neuroendocrine communication. Clin Ther 37(5):954–967. https://doi.org/10.1016/j.clinthera.2015.03.002

77. Marshall JS, Warrington R, Watson W et al (2018) An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol 14(Suppl 2):49. https://doi.org/10.1186/s13223-018-0278-1

78. Bilbo SD, Schwarz JM (2012) The immune system and developmental programming of brain and behavior. Front Neuroendocrinol 33(3):267–286. https://doi.org/10.1016/j.yfrne.2012.08.006

79. Deshmukh HS, Liu YH, Menkiti OR et al (2014) The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 20(5):524–530. https://doi.org/10.1038/nm.3542

80. Konieczna P, Akdis CA, Quigley EMM et al (2012) Portrait of an immunoregulatory bifidobacterium. Gut Microbes 3(3):261–266. https://doi.org/10.4161/gmic.20358

81. Abt MC, Osborne LC, Monticelli LA et al (2012) Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37(1):158–170. https://doi.org/10.1016/j.immuni.2012.04.011

82. O’Mahony SM, Marchesi JR, Scully P et al (2009) Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65(3):263–267. https://doi.org/10.1016/j.biopsych.2008.06.026

83. Foster JA, Rinaman L, Cryan JF (2017) Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress 7:124–136. https://doi.org/10.1016/j.ynstr.2017.03.001

84. Parada Venegas D, De la Fuente MK, Landskron G et al (2019) Corrigendum: short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:1486. https://doi.org/10.3389/fimmu.2019.00277

85. Sleeth ML, Thompson EL, Ford HE et al (2010) Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr Res Rev 23(1):135–145. https://doi.org/10.1017/S0954422410000089

86. Maurer MH, Canis M, Kuschinsky W et al (2004) Correlation between local monocarboxylate transporter 1 (MCT1) and glucose transporter 1 (GLUT1) densities in the adult rat brain. Neurosci Lett 355(1):105–108. https://doi.org/10.1016/j.neulet.2003.10.056

87. Dalile B, Van Oudenhove L, Vervliet B et al (2019) The role of short-chain fatty acids in microbiota–gut–brain communication. Nat Rev Gastroenterol Hepatol 16(8):461–478. https://doi.org/10.1038/s41575-019-0157-3

88. Chang PV, Hao LM, Offermanns S et al (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 111(6):2247–2252. https://doi.org/10.1073/pnas.1322269111

89. Govindarajan N, Agis-Balboa RC, Walter J et al (2011) Sodium butyrate improves memory function in an alzheimer’s disease mouse model when administered at an advanced stage of disease progression. J Alzheimer Dis 26(1):187–197. https://doi.org/10.3233/JAD-2011-110080

90. MacFabe DF (2012) Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis 23(1):19260. https://doi.org/10.3402/mehd.v23i0.19260

91. MacFabe DF, Cain NE, Boon F et al (2011) Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res 217(1):47–54. https://doi.org/10.1016/j.bbr.2010.10.005

92. Schroeder FA, Lin CL, Crusio WE et al (2007) Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62(1):55–64. https://doi.org/10.1016/j.biopsych.2006.06.036

93. Nogal A, Valdes AM, Menni C (2021) The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes 13(1):e1897212. https://doi.org/10.1080/19490976.2021.1897212

94. Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol 11:25. https://doi.org/10.3389/fendo.2020.00025

95. Kang DW, Adams JB, Gregory AC et al (2017) Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5(1):10. https://doi.org/10.1186/s40168-016-0225-7

96. Góra B, Gofron Z, Grosiak M et al (2018) Toxin profile of fecal Clostridium perfringens strains isolated from children with autism spectrum disorders. Anaerobe 51:73–77. https://doi.org/10.1016/j.anaerobe.2018.03.005

97. Tabouy L, Getselter D, Ziv O et al (2018) Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders. Brain Behav Immun 73:310–319. https://doi.org/10.1016/j.bbi.2018.05.015

98. Sgritta M, Dooling SW, Buffington SA et al (2019) Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron 101(2):246-259.e6. https://doi.org/10.1016/j.neuron.2018.11.018

99. Golubeva AV, Joyce SA, Moloney G et al (2017) Microbiota-related changes in bile acid & tryptophan metabolism are associated with gastrointestinal dysfunction in a mouse model of autism. EBioMedicine 24(C):166–178. https://doi.org/10.1016/j.ebiom.2017.09.020

100. Emanuele E, Orsi P, Boso M et al (2010) Low-grade endotoxemia in patients with severe autism. Neurosci Lett 471(3):162–165. https://doi.org/10.1016/j.neulet.2010.01.033

101. Finegold SM, Dowd SE, Gontcharova V et al (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16(4):444–453. https://doi.org/10.1016/j.anaerobe.2010.06.008

102. Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701–712. https://doi.org/10.1038/nrn3346

103. Mertsalmi TH, Aho VTE, Pereira PAB et al (2017) More than constipation–bowel symptoms in Parkinson’s disease and their connection to gut microbiota. Eur J Neurol 24(11):1375–1383. https://doi.org/10.1111/ene.13398

104. Keshavarzian A, Green SJ, Engen PA et al (2015) Colonic bacterial composition in Parkinson’s disease. Movement Disord 30(10):1351–1360. https://doi.org/10.1002/mds.26307

105. Killinger BA, Madaj Z, Sikora JW et al (2018) The vermiform appendix impacts the risk of developing Parkinson’s disease. Sci Transl Med 10(465):eaar5280. https://doi.org/10.1126/scitranslmed.aar5280

106. Sampson TR, Debelius JW, Thron T et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167(6):1469-1480.e12. https://doi.org/10.1016/j.cell.2016.11.018

107. Bhattacharyya D, Mohite GM, Krishnamoorthy J et al (2019) Lipopolysaccharide from gut microbiota modulates α-synuclein aggregation and alters its biological function. ACS Chem Neurosci 10(5):2229–2236. https://doi.org/10.1021/acschemneuro.8b00733

108. Holmqvist S, Chutna O, Bousset L et al (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128(6):805–820. https://doi.org/10.1007/s00401-014-1343-6

109. Scheperjans F, Aho V, Pereira PAB et al (2015) Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 30(3):350–358. https://doi.org/10.1002/mds.26069

110. Hill-Burns EM, Debelius JW, Morton JT et al (2017) Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739–749. https://doi.org/10.1002/mds.26942

111. Huang YD, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204–1222. https://doi.org/10.1016/j.cell.2012.02.040

112. Van Gerven N, Van der Verren SE, Reiter DM et al (2018) The role of functional amyloids in bacterial virulence. J Mol Biol 430(20):3657–3684. https://doi.org/10.1016/j.jmb.2018.07.010

113. Cattaneo A, Cattane N, Galluzzi S et al (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49:60–68. https://doi.org/10.1016/j.neurobiolaging.2016.08.019

114. Aso E, Sánchez-Pla A, Vegas-Lozano E et al (2015) Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice. J Alzheimer Dis 43(3):977–991. https://doi.org/10.3233/JAD-141014

115. Vogt NM, Kerby RL, Dill-McFarland KA et al (2017) Gut microbiome alterations in Alzheimer’s disease. Sci Rep 7(1):13537. https://doi.org/10.1038/s41598-017-13601-y

116. Radde R, Bolmont T, Kaeser SA et al (2006) Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7(9):940–946. https://doi.org/10.1038/sj.embor.7400784

117. Harach T, Marungruang N, Duthilleul N et al (2017) Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep 7(1):41802. https://doi.org/10.1038/srep41802

118. Kobayashi Y, Sugahara H, Shimada K et al (2017) Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease. Sci Rep 7(1):13510. https://doi.org/10.1038/s41598-017-13368-2

119. Ceppa FA, Izzo L, Sardelli L et al (2020) Human gut-microbiota interaction in neurodegenerative disorders and current engineered tools for its modeling. Front Cell Infect Microbiol 10:297. https://doi.org/10.3389/fcimb.2020.00297

120. Coluccio ML, Perozziello G, Malara N et al (2019) Microfluidic platforms for cell cultures and investigations. Microelectron Eng 208:14–28. https://doi.org/10.1016/j.mee.2019.01.004

121. Garcia-Corral M (2020) Towards an integrated microbiome-gut-brain axis-on-chip platform. MS Thesis, University of Twente. https://purl.utwente.nl/essays/85036

122. Dingle YTL, Boutin ME, Chirila AM et al (2015) Three-dimensional neural spheroid culture: an in vitro model for cortical studies. Tissue Eng Part C Methods 21(12):1274–1283. https://doi.org/10.1089/ten.tec.2015.0135

123. Boutin ME, Kramer LL, Livi LL et al (2018) A three-dimensional neural spheroid model for capillary-like network formation. J Neurosci Methods 299:55–63. https://doi.org/10.1016/j.jneumeth.2017.01.014

124. Park J, Lee BK, Jeong GS et al (2015) Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer’s disease. Lab Chip 15(1):141–150. https://doi.org/10.1039/c4lc00962b

125. Kim YH, Choi SH, D’Avanzo C et al (2015) A 3D human neural cell culture system for modeling Alzheimer’s disease. Nat Protoc 10(7):985–1006. https://doi.org/10.1038/nprot.2015.065

126. Simão D, Pinto C, Piersanti S et al (2015) Modeling human neural functionality in vitro: three-dimensional culture for dopaminergic differentiation. Tissue Eng Part A 21(3–4):654–668. https://doi.org/10.1089/ten.tea.2014.0079

127. Cho CF, Wolfe JM, Fadzen CM et al (2017) Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat Commun 8(1):15623. https://doi.org/10.1038/ncomms15623

128. Urich E, Patsch C, Aigner S et al (2013) Multicellular self-assembled spheroidal model of the blood brain barrier. Sci Rep 3(1):1500. https://doi.org/10.1038/srep01500

129. Zhuang P, Sun AX, An J et al (2018) 3D neural tissue models: from spheroids to bioprinting. Biomaterials 154:113–133. https://doi.org/10.1016/j.biomaterials.2017.10.002

130. Han H, Park Y, Choi Y et al (2022) A bioprinted tubular intestine model using a colon-specific extracellular matrix bioink. Adv Healthc Mater 11(2):e2101768. https://doi.org/10.1002/adhm.202101768

131. Santos JLD, Araujo CD, Rocha CAG et al (2023) Modeling autism spectrum disorders with Induced pluripotent stem cell-derived brain organoids. Biomolecules 13(2):260. https://doi.org/10.3390/biom13020260

132. Lee HK, Velazquez Sanchez C, Chen M et al (2016) Three dimensional human neuro-spheroid model of Alzheimer’s disease based on differentiated induced pluripotent stem cells. PLoS ONE 11(9):e0163072. https://doi.org/10.1371/journal.pone.0163072

133. Choi YJ, Park JS, Lee SH (2013) Size-controllable networked neurospheres as a 3D neuronal tissue model for Alzheimer’s disease studies. Biomaterials 34(12):2938–2946. https://doi.org/10.1016/j.biomaterials.2013.01.038

134. Birey F, Andersen J, Makinson CD et al (2017) Assembly of functionally integrated human forebrain spheroids. Nature 545(7652):54–59. https://doi.org/10.1038/nature22330

135. Modafferi S, Zhong XL, Kleensang A et al (2021) Gene–environment interactions in developmental neurotoxicity: a case study of synergy between chlorpyrifos and CHD8 knockout in human brainspheres. Environ Health Perspect 129(7):77001. https://doi.org/10.1289/EHP8580

136. Pamies D, Barreras P, Block K et al (2017) A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity. ALTEX Altern Anim Exp 34(3):362–376. https://doi.org/10.14573/altex.1609122

137. Wang P, Lin MY, Pedrosa E et al (2015) CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment. Mol Autism 6(1):55. https://doi.org/10.1186/s13229-015-0048-6

138. Adhya D, Chennell G, Crowe JA et al (2021) Application of airy beam light sheet microscopy to examine early neurodevelopmental structures in 3D hiPSC-derived human cortical spheroids. Mol Autism 12(1):4. https://doi.org/10.1186/s13229-021-00413-1

139. Hentschel V, Seufferlein T, Armacki M (2021) Intestinal organoids in coculture: redefining the boundaries of gut mucosa ex vivo modeling. Am J Physiol Gastrointest Liver Physiol 321(6):G693–G704. https://doi.org/10.1152/AJPGI.00043.2021

140. Chang Y, Kim J, Park H et al (2020) Modelling neurodegenerative diseases with 3D brain organoids. Biol Rev Cambridge Philos Soc 95(5):1497–1509. https://doi.org/10.1111/brv.12626

141. Lancaster MA, Renner M, Martin CA et al (2013) Cerebral organoids model human brain development and microcephaly. Nature 501(7467):373–379. https://doi.org/10.1038/nature12517

142. Jo J, Xiao YX, Sun AX et al (2016) Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons. Cell Stem Cell 19(2):248–257. https://doi.org/10.1016/j.stem.2016.07.005

143. McCracken KW, Catá EM, Crawford CM et al (2014) Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516(7531):400–404. https://doi.org/10.1038/nature13863

144. Williamson IA, Arnold JW, Samsa LA et al (2018) A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology. CMGH 6(3):301–319. https://doi.org/10.1016/j.jcmgh.2018.05.004

145. Noel G, Baetz NW, Staab JF et al (2017) A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions. Sci Rep 7(1):45270. https://doi.org/10.1038/srep45270

146. Dutta D, Heo I, Clevers H (2017) Disease modeling in stem cell-derived 3D organoid systems. Trends Mol Med 23(5):393–410. https://doi.org/10.1016/j.molmed.2017.02.007

147. Zhao ZX, Chen XY, Dowbaj AM et al (2022) Organoids. Nat Rev Methods Primers 2(1):94. https://doi.org/10.1038/s43586-022-00174-y

148. Grebenyuk S, Ranga A (2019) Engineering organoid vascularization. Front Bioeng Biotechnol 7:39. https://doi.org/10.3389/fbioe.2019.00039

149. Ormel PR, Vieira de Sá R, van Bodegraven EJ et al (2018) Microglia innately develop within cerebral organoids. Nat Commun 9(1):4167. https://doi.org/10.1038/s41467-018-06684-2

150. Raja WK, Mungenast AE, Lin YT et al (2016) Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer’s disease phenotypes. PLoS ONE 11(9):e0161969. https://doi.org/10.1371/journal.pone.0161969

151. Gonzalez C, Armijo E, Bravo-Alegria J et al (2018) Modeling amyloid beta and tau pathology in human cerebral organoids. Mol Psychiatry 23(12):2363–2374. https://doi.org/10.1038/s41380-018-0229-8

152. Bi FC, Yang XH, Cheng XY et al (2021) Optimization of cerebral organoids: a more qualified model for Alzheimer’s disease research. Transl Neurodegener 10(1):27. https://doi.org/10.1186/s40035-021-00252-3

153. Pérez MJ, Ivanyuk D, Panagiotakopoulou V et al (2021) Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer’s disease-like pathology in human cerebral organoids. Mol Psychiatry 26(10):5733–5750. https://doi.org/10.1038/s41380-020-0807-4

154. Monzel AS, Smits LM, Hemmer K et al (2017) Derivation of human midbrain-specific organoids from neuroepithelial stem cells. Stem Cell Rep 8(5):1144–1154. https://doi.org/10.1016/j.stemcr.2017.03.010

155. Chlebanowska P, Tejchman A, Sułkowski M et al (2020) Use of 3D organoids as a model to study idiopathic form of Parkinson’s disease. Int J Mol Sci 21(3):694. https://doi.org/10.3390/ijms21030694

156. Kwak TH, Kang JH, Hali S et al (2020) Generation of homogeneous midbrain organoids with in vivo: like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling. Stem Cells 38(6):727–740. https://doi.org/10.1002/stem.3163

157. Spence JR, Mayhew CN, Rankin SA et al (2011) Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470(7332):105–110. https://doi.org/10.1038/nature09691

158. Yamada S, Kanda Y (2019) Retinoic acid promotes barrier functions in human iPSC-derived intestinal epithelial monolayers. J Pharmacol Sci 140(4):337–344. https://doi.org/10.1016/j.jphs.2019.06.012

159. Hill DR, Huang S, Nagy MS et al (2017) Bacterial colonization stimulates a complex physiological response in the immature human intestinal epithelium. eLife 6:e29132. https://doi.org/10.7554/eLife.29132

160. Workman MJ, Mahe MM, Trisno S et al (2017) Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Nat Med 23(1):49–59. https://doi.org/10.1038/nm.4233

161. Han H, Jang J (2022) Recent advances in biofabricated gut models to understand the gut-brain axis in neurological diseases. Front Med Technol 4:931411. https://doi.org/10.3389/fmedt.2022.931411

162. Ulluwishewa D, Anderson RC, Young W et al (2015) Live Faecalibacterium prausnitzii in an apical anaerobic model of the intestinal epithelial barrier. Cell Microbiol 17(2):226–240. https://doi.org/10.1111/cmi.12360

163. Hubatsch I, Ragnarsson EGE, Artursson P (2007) Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc 2(9):2111–2119. https://doi.org/10.1038/nprot.2007.303

164. Hall V, Bendtsen KMS (2023) Getting closer to modeling the gut-brain axis using induced pluripotent stem cells. Front Cell Dev Biol 11:1146062. https://doi.org/10.3389/fcell.2023.1146062

165. Hilgendorf C, Spahn-Langguth H, Regårdh CG et al (2000) Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 89(1):63–75. https://doi.org/10.1002/(SICI)1520-6017(200001)89:1%3c63::AID-JPS7%3e3.0.CO;2-6

166. Lozoya-Agullo I, Araújo F, González-Álvarez I et al (2017) Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B coculture models to predict intestinal and colonic permeability compared to Caco-2 monoculture. Mol Pharm 14(4):1264–1270. https://doi.org/10.1021/acs.molpharmaceut.6b01165

167. Raimondi I, Izzo L, Tunesi M et al (2020) Organ-on-a-chip in vitro models of the brain and the blood-brain barrier and their value to study the microbiota-gut-brain axis in neurodegeneration. Front Bioeng Biotechnol 7:435. https://doi.org/10.3389/fbioe.2019.00435

168. Moysidou CM, Owens RM (2021) Advances in modelling the human microbiome-gut-brain axis in vitro. Biochem Soc Trans 49(1):187–201. https://doi.org/10.1042/BST20200338

169. Kim HJ, Huh D, Hamilton G et al (2012) Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12(12):2165–2174. https://doi.org/10.1039/c2lc40074j

170. Shin W, Kim HJ (2018) Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci USA 115(45):E10539–E10547. https://doi.org/10.1073/pnas.1810819115

171. Shin W, Wu A, Massidda MW et al (2019) A robust longitudinal co-culture of obligate anaerobic gut microbiome with human intestinal epithelium in an anoxic–oxic interface-on-a-chip. Front Bioeng Biotechnol 7:13. https://doi.org/10.3389/fbioe.2019.00013

172. Booth R, Kim H (2012) Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). Lab Chip 12(10):1784–1792. https://doi.org/10.1039/c2lc40094d

173. Griep LM, Wolbers F, De Wagenaar B et al (2013) BBB on CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices 15(1):145–150. https://doi.org/10.1007/s10544-012-9699-7

174. Raimondi MT, Albani D, Giordano C (2019) An organ-on-a-chip engineered platform to study the microbiota–gut–brain axis in neurodegeneration. Trends Mol Med 25(9):737–740. https://doi.org/10.1016/j.molmed.2019.07.006

175. Moysidou CM, Withers AM, Nisbet AJ et al (2022) Investigation of host–microbe–parasite interactions in an in vitro 3D model of the vertebrate gut. Adv Biol 6(8):e2200015. https://doi.org/10.1002/adbi.202200015

176. Vincentini O, Prota V, Cecchetti S et al (2022) Towards the standardization of intestinal in vitro advanced barrier model for nanoparticles uptake and crossing: the SiO2 case study. Cells 11(21):3357. https://doi.org/10.3390/cells11213357

177. Rubio APD, Martínez J, Palavecino M et al (2020) Transcytosis of bacillus subtilis extracellular vesicles through an in vitro intestinal epithelial cell model. Sci Rep 10(1):3120. https://doi.org/10.1038/s41598-020-60077-4

178. Deloid GM, Cao XQ, Molina RM et al (2019) Toxicological effects of ingested nanocellulose in in vitro intestinal epithelium and in vivo rat models. Environ Sci Nano 6(7):2105–2115. https://doi.org/10.1039/c9en00184k

179. di Vito R, Di Mezza A, Conte C et al (2023) The crosstalk between intestinal epithelial cells and mast cells is modulated by the probiotic supplementation in co-culture models. Int J Mol Sci 24(4):4157. https://doi.org/10.3390/ijms24044157

180. Zeuthen LH, Fink LN, Frokiaer H (2008) Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-β. Immunology 123(2):197–208. https://doi.org/10.1111/j.1365-2567.2007.02687.x

181. Le NPK, Altenburger MJ, Lamy E (2023) Development of an inflammation-triggered in vitro “leaky gut” model using caco-2/HT29-MTX-E12 combined with macrophage-like THP-1 cells or primary human-derived macrophages. Int J Mol Sci 24(8):7427. https://doi.org/10.3390/ijms24087427

182. McCright J, Sinha A, Maisel K (2022) Generating an in vitro gut model with physiologically relevant biophysical mucus properties. Cell Mol Bioeng 15(5):479–491. https://doi.org/10.1007/s12195-022-00740-0

183. Denaro M, Smeriglio A, De Francesco C et al (2020) In vitro intestinal transport and anti-inflammatory properties of ideain across Caco-2 transwell model. Fitoterapia 146:104723. https://doi.org/10.1016/j.fitote.2020.104723

184. Zeng J, Teng F, Weinstock GM et al (2004) Translocation of enterococcus faecalis strains across a monolayer of polarized human enterocyte-like T84 cells. J Clin Microbiol 42(3):1149–1154. https://doi.org/10.1128/JCM.42.3.1149-1154.2004

185. Krishnan M, Penrose HM, Shah NN et al (2016) VSL#3 probiotic stimulates T-cell protein tyrosine phosphatase-mediated recovery of IFN-γ-induced intestinal epithelial barrier defects. Inflamm Bowel Dis 22(12):2811–2823. https://doi.org/10.1097/MIB.0000000000000954

186. Haller D, Bode C, Hammes WP et al (2000) Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47(1):79–87. https://doi.org/10.1136/gut.47.1.79

187. Dosh RH, Essa A, Jordan-Mahy N et al (2017) Use of hydrogel scaffolds to develop an in vitro 3D culture model of human intestinal epithelium. Acta Biomater 62:128–143. https://doi.org/10.1016/j.actbio.2017.08.035

188. Mulder D, Aarts E, Arias Vasquez A et al (2023) A systematic review exploring the association between the human gut microbiota and brain connectivity in health and disease. Mol Psychiatr 28:5037–5061.